Early research (Phase 1)Study completedNCT00000886
What this trial is testing
A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24